IDT vs DXC Technology: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

IDT Corporation (IDT)

Q3 202629 Aug – 9 Oct 2026

▲2▼2

IDT's growth units now drive profit, but remittance tax and weak retail sales weigh

Growth businesses now generate most profit IDT's three growth units — NRS, BOSS Money, and net2phone — now produce about two-thirds of gross profit and 53% of adjusted EBITDA, even though they are only a third of revenue. That mix shift lifts profit quality and supports the stock.
This is the core structural reason IDT is moving: profit is increasingly coming from faster-growing, higher-margin businesses.
Record FY2026 results and strong FY2027 guidance IDT reported record full-year results with gross profit up 18% and guided FY2027 adjusted EBITDA to $176–$180 million. Management also declared a regular dividend. Solid guidance gives investors confidence in continued growth.
The earnings report and guidance are the main new hard numbers that directly affect how investors value IDT.
New federal tax hits cash remittances A new federal tax on cash-originated remittances cut retail money-transfer revenue from the retailer agent channel by 17%. That is a real drag on the legacy business and could keep weighing on overall growth.
This is the clearest new negative force on IDT's results and a genuine counterweight to the growth story.
Weak August same-store sales at NRS retailers August same-store sales at independent retailers on IDT's NRS network fell 1.1% and units sold dropped 1.6%, after a 3.3% gain in July. Softer consumer demand at those stores can slow NRS growth and is a caution flag.
It shows a real demand headwind inside IDT's fastest-growing segment, balancing the positive growth narrative.

September 202629 Aug – 9 Oct 2026

▲2▼2

IDT's growth units now drive profit, but remittance tax and weak retail sales weigh

Growth businesses now generate most profit IDT's three growth units — NRS, BOSS Money, and net2phone — now produce about two-thirds of gross profit and 53% of adjusted EBITDA, even though they are only a third of revenue. That mix shift lifts profit quality and supports the stock.
This is the core structural reason IDT is moving: profit is increasingly coming from faster-growing, higher-margin businesses.
Record FY2026 results and strong FY2027 guidance IDT reported record full-year results with gross profit up 18% and guided FY2027 adjusted EBITDA to $176–$180 million. Management also declared a regular dividend. Solid guidance gives investors confidence in continued growth.
The earnings report and guidance are the main new hard numbers that directly affect how investors value IDT.
New federal tax hits cash remittances A new federal tax on cash-originated remittances cut retail money-transfer revenue from the retailer agent channel by 17%. That is a real drag on the legacy business and could keep weighing on overall growth.
This is the clearest new negative force on IDT's results and a genuine counterweight to the growth story.
Weak August same-store sales at NRS retailers August same-store sales at independent retailers on IDT's NRS network fell 1.1% and units sold dropped 1.6%, after a 3.3% gain in July. Softer consumer demand at those stores can slow NRS growth and is a caution flag.
It shows a real demand headwind inside IDT's fastest-growing segment, balancing the positive growth narrative.

Latest29 Aug – 9 Oct 2026

▲2▼2

IDT's growth units now drive profit, but remittance tax and weak retail sales weigh

Growth businesses now generate most profit IDT's three growth units — NRS, BOSS Money, and net2phone — now produce about two-thirds of gross profit and 53% of adjusted EBITDA, even though they are only a third of revenue. That mix shift lifts profit quality and supports the stock.
This is the core structural reason IDT is moving: profit is increasingly coming from faster-growing, higher-margin businesses.
Record FY2026 results and strong FY2027 guidance IDT reported record full-year results with gross profit up 18% and guided FY2027 adjusted EBITDA to $176–$180 million. Management also declared a regular dividend. Solid guidance gives investors confidence in continued growth.
The earnings report and guidance are the main new hard numbers that directly affect how investors value IDT.
New federal tax hits cash remittances A new federal tax on cash-originated remittances cut retail money-transfer revenue from the retailer agent channel by 17%. That is a real drag on the legacy business and could keep weighing on overall growth.
This is the clearest new negative force on IDT's results and a genuine counterweight to the growth story.
Weak August same-store sales at NRS retailers August same-store sales at independent retailers on IDT's NRS network fell 1.1% and units sold dropped 1.6%, after a 3.3% gain in July. Softer consumer demand at those stores can slow NRS growth and is a caution flag.
It shows a real demand headwind inside IDT's fastest-growing segment, balancing the positive growth narrative.

DXC Technology Co (DXC)

Q3 202623 Jun – 8 Oct 2026

▲2▼2

DXC's AI progress offset by revenue decline and legal probe

TCS trade secrets payment DXC collected $213.56 million from Tata Consultancy Services after a trade secrets ruling, a one-time cash boost that strengthens its balance sheet.
This cash inflow was a major positive event in the quarter.
AI pivot and partnerships DXC advanced its AI pivot through partnerships with Anthropic, ElevenLabs, and Primary, and launched AI-native workplace and insurance tools, helping insurance software, SaaS, and AI revenue grow 24%.
AI progress was a key positive driver for the stock.
Securities fraud investigation A securities fraud investigation tied to May’s earnings miss added legal uncertainty, weighing on investor sentiment.
This legal issue was a significant negative factor during the quarter.
Revenue decline and weak guidance Revenue fell about 5% year over year, EPS missed estimates, and guidance pointed to a 3%–5% organic decline, suggesting AI progress may not durably lift the stock until shrinkage stops.
Ongoing revenue decline and weak guidance pressured the stock.

August 202621 Jul – 8 Oct 2026

▲3▼1

DXC's AI pivot gains traction as insurance software grows, but revenue still shrinks

AI partnerships and new products build the turnaround story DXC added Anthropic, ElevenLabs and Primary partnerships plus AI-native workplace and insurance tools. These aim to shift DXC toward higher-value AI work, which could lift future sales and margins if clients adopt them. For now they are building blocks, not yet a fix for falling revenue.
This is the core new strategic push that could change DXC's long-term growth trajectory.
Insurance software and AI revenue growing 24% DXC said recurring software, SaaS and AI revenue in its insurance business is growing 24%, supported by products like OASIS and Assure Smart Apps. This is a rare fast-growing piece inside a company whose overall revenue is shrinking, and it supports the idea that DXC can grow again.
It is the clearest new evidence that part of DXC is actually growing, which investors care about.
Revenue keeps falling and profit missed expectations DXC's quarterly revenue fell about 5% from a year earlier and earnings per share missed analyst estimates, sending the stock down 6.6%. Management still guides organic revenue to decline 3% to 5% this fiscal year. Until that decline stops, the AI story alone may not lift the stock durably.
It is the main counterweight: the core business is still shrinking and profit disappointed.
Accenture's strong outlook eased AI-disruption fears for IT services After Accenture reported better results and a solid outlook, DXC shares rose 5.7% in sympathy. The read-across signaled that AI is not hollowing out demand for traditional consulting and outsourcing as fast as some feared, which helps DXC's whole sector.
It shows an external demand signal that directly moved DXC and the wider IT services group.

Latest21 Jul – 8 Oct 2026

▲3▼1

DXC's AI pivot gains traction as insurance software grows, but revenue still shrinks

AI partnerships and new products build the turnaround story DXC added Anthropic, ElevenLabs and Primary partnerships plus AI-native workplace and insurance tools. These aim to shift DXC toward higher-value AI work, which could lift future sales and margins if clients adopt them. For now they are building blocks, not yet a fix for falling revenue.
This is the core new strategic push that could change DXC's long-term growth trajectory.
Insurance software and AI revenue growing 24% DXC said recurring software, SaaS and AI revenue in its insurance business is growing 24%, supported by products like OASIS and Assure Smart Apps. This is a rare fast-growing piece inside a company whose overall revenue is shrinking, and it supports the idea that DXC can grow again.
It is the clearest new evidence that part of DXC is actually growing, which investors care about.
Revenue keeps falling and profit missed expectations DXC's quarterly revenue fell about 5% from a year earlier and earnings per share missed analyst estimates, sending the stock down 6.6%. Management still guides organic revenue to decline 3% to 5% this fiscal year. Until that decline stops, the AI story alone may not lift the stock durably.
It is the main counterweight: the core business is still shrinking and profit disappointed.
Accenture's strong outlook eased AI-disruption fears for IT services After Accenture reported better results and a solid outlook, DXC shares rose 5.7% in sympathy. The read-across signaled that AI is not hollowing out demand for traditional consulting and outsourcing as fast as some feared, which helps DXC's whole sector.
It shows an external demand signal that directly moved DXC and the wider IT services group.

July 202623 Jun – 30 Jul 2026

▲2▼2

DXC's Weak Earnings and Legal Probe Weigh on Shares

Securities Fraud Investigation Pomerantz LLP is investigating DXC for possible securities fraud tied to its May 7 earnings miss, which already caused a 21% stock drop. The probe adds legal uncertainty and could lead to fines or lawsuits, making investors more cautious and pressuring the stock.
This is a new legal risk that directly threatens DXC's finances and reputation, explaining recent price weakness.
Wins $213.56 Million in Trade Secrets Case DXC collected $213.56 million from Tata Consultancy Services after the Supreme Court upheld a trade secrets ruling. This cash boost strengthens DXC's balance sheet and shows it will defend its intellectual property, a positive for investors.
This is a new, concrete financial gain that improves DXC's cash position and could support future investments.
Launches Private Cloud+ for Regulated Industries DXC launched Private Cloud+, a hybrid cloud solution for sensitive workloads in finance, healthcare, and government. This expands its product lineup and targets high-value clients, potentially boosting future revenue and showing innovation.
This is a new product that could drive demand and revenue growth, a positive strategic move.
IBM Warning and Weak Q2 Earnings IBM's revenue warning signaled stalled enterprise deals, dragging DXC shares down 4.2%. Then DXC's Q2 adjusted EPS missed estimates by 11.3% and next-quarter revenue guidance was below expectations, sending shares down another 5.2%. These reinforce concerns about weak demand and execution.
These are new negative developments that directly impact DXC's earnings and investor confidence, explaining recent price declines.

23 Jun – 30 Jul 2026

▲2▼2

DXC's Weak Earnings and Legal Probe Weigh on Shares

Securities Fraud Investigation Pomerantz LLP is investigating DXC for possible securities fraud tied to its May 7 earnings miss, which already caused a 21% stock drop. The probe adds legal uncertainty and could lead to fines or lawsuits, making investors more cautious and pressuring the stock.
This is a new legal risk that directly threatens DXC's finances and reputation, explaining recent price weakness.
Wins $213.56 Million in Trade Secrets Case DXC collected $213.56 million from Tata Consultancy Services after the Supreme Court upheld a trade secrets ruling. This cash boost strengthens DXC's balance sheet and shows it will defend its intellectual property, a positive for investors.
This is a new, concrete financial gain that improves DXC's cash position and could support future investments.
Launches Private Cloud+ for Regulated Industries DXC launched Private Cloud+, a hybrid cloud solution for sensitive workloads in finance, healthcare, and government. This expands its product lineup and targets high-value clients, potentially boosting future revenue and showing innovation.
This is a new product that could drive demand and revenue growth, a positive strategic move.
IBM Warning and Weak Q2 Earnings IBM's revenue warning signaled stalled enterprise deals, dragging DXC shares down 4.2%. Then DXC's Q2 adjusted EPS missed estimates by 11.3% and next-quarter revenue guidance was below expectations, sending shares down another 5.2%. These reinforce concerns about weak demand and execution.
These are new negative developments that directly impact DXC's earnings and investor confidence, explaining recent price declines.